EQT seals $9.6bn sale of Covid vaccine DNA supplier Aldevron, less than two years after buyout

Private equity major EQT has agreed a $9.6bn sale of vaccine DNA and mRNA supplier Aldevron to Danaher Corp, just two years after buying into the business.